US announces crackdown on copycat weight-loss drugs - Financial Times
- US announces crackdown on copycat weight-loss drugs Financial Times
- Health Agency Refers Knockoff GLP-1 Provider Hims & Hers to Justice Department The Wall Street Journal
- US signals crackdown on compounded weight-loss drugs; Hims shares tumble CNBC
- FDA to Restrict Copycat Weight Loss Drugs Sold by Pharma Rivals (HIMS) bloomberg.com
- Hims & Hers launches Wegovy knockoff pill, drugmaker Novo Nordisk vows to sue PBS